Aviva PLC Horizon Therapeutics Public LTD CO Transaction History

Aviva PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $855,781 - $1 Million	8,646 Added 36.48%	32,349 $3.74 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $13.6 Million - $15.9 Million	-141,111 Reduced 85.62%	23,703 $2.44 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $19.2 Million - $20.3 Million	-178,612 Reduced 52.01%	164,814 $18 Million
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $1.5 Million - $2.74 Million	24,062 Added 7.53%	343,426 $39.1 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $3.39 Million - $4.87 Million	57,497 Added 21.96%	319,364 $19.8 Million
Q2 2022 Aug 04, 2022	BUY	$79.4 - $116.36 $8.36 Million - $12.2 Million	105,274 Added 67.23%	261,867 $20.9 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $6.84 Million - $8.7 Million	79,185 Added 102.3%	156,593 $16.5 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $887 - $1,079	9 Added 0.01%	77,408 $8.34 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $656,145 - $787,931	7,139 Added 10.16%	77,399 $8.48 Million
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $479,235 - $533,027	5,557 Added 8.59%	70,260 $6.58 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $4.65 Million - $6.18 Million	64,703 New	64,703 $5.96 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.